The introduction of Xylazine and Tranq into the current drug supply has created a new set of symptoms and treatment realities in the field. This training examines what prevention specialists need to know about these new substances and how to shift their expectations and interventions in preventing the adoption and use of these new derivatives.

LEARNING OBJECTIVES: At the end of this training, participants will be able to:

• Name the current side-effects that Xylazine and Tranq have introduced into the field of substance use.
• Explain how these trends effect prevention work and efforts.
• Apply strategies for engaging clients who are in danger of Xylazine and Tranq use.